Introduction
Sleep of insufficient quality and/or duration is a prevalent and concerning health issue in North America. 1, 2 Individuals who report poor sleep or "trouble sleeping" most often experience symptoms of insomnia characterized by difficulty initiating and/or maintaining sleep, despite having adequate opportunity for sleep, and feel that this causes significant daytime impairment. When these sleep disturbances happen more than 3 times per week for at least 3 months, individuals may meet the diagnostic criteria for insomnia disorder. 3 Individuals with insomnia symptoms are at higher risk for many physical health problems, including diabetes, 4 obesity, 5 and cardiovascular diseases (e.g., stroke, hypertension, and heart attack). 6 In addition to the impact on physical health, poor sleep adversely impacts mental health. Sleep of insufficient quality and/or duration has been linked to mood and anxiety disorders, 7, 8 higher levels of perceived stress, 9 and impaired cognitive functioning. 7 Sleep problems have severe economic consequences for the individual and society at large. 10 Insomnia symptoms have been linked to impaired work performance, increased disability and absenteeism, and increased use of health care services. 7 It is estimated that the annual cost of insomnia is $6.6 billion (CAN), which includes the direct costs of insomnia-motivated health care use, prescription medications, and over-the-counter medications. The estimated annual perperson costs (both direct and indirect) of individuals with insomnia ($5010) and individuals with some insomnia symptoms ($1431) are far greater than those who obtain good quality sleep ($421).
The majority of the annual financial loss, though, is attributable to the indirect expenses of work absenteeism and loss of productivity associated with insomnia. 7 Common risk factors for insomnia include older age, female sex, low socioeconomic status, depression, anxiety, chronic health conditions, smoking, and substance use. 11, 12 Previous studies have postulated that the increasing prevalence of insomnia symptoms may be due in part to the many societal changes that have occurred in recent years, particularly the development of a 24-hour society, growing frequency of technology use, higher rates of obesity and diabetes, increases in irregular work hours, and work stress. 1, 13, 14 It is likely that there have been changes at the population level in behavioral, psychosocial, and health-related risk factors for insomnia in the aforementioned areas, but further research is required to understand the causal pathways of these relationships. Although the increasing prevalence of insomnia has been documented in several other industrialized countries, 1, [13] [14] [15] this phenomenon has not yet been examined in the Canadian population. The objectives of this study were to:
1. Characterize and compare the prevalence of insomnia symptoms in the Canadian population between 2002 and 2012; 2. Identify sociodemographic and psychosocial predictors of trouble sleeping.
A better understanding of the factors related to trouble sleeping is necessary to effectively identify groups at risk for insomnia disorder and to inform the development of future prevention and intervention initiatives.
Methods

Participants
This study used data from the Canadian Community Health Survey-Mental Health (CCHS-MH) 2002 and 2012 cycles. The CCHS-MH is a national, cross-sectional survey that evaluated the mental health status of Canadians, with emphasis on mental health disorders, access to care and service use, level of functioning, potential relationships between sociodemographic variables and mental health, and assessment of changes over time.
Participants were chosen for the CCHS-MH in 3 stages. First, geographical regions known as clusters were selected. Households were then selected within each cluster, and 1 member of each household was selected at random. The number of households selected in each province was proportionate to the population of that province. Individuals from the 10 Canadian provinces over the age of 15 were eligible for participation. The following groups were excluded from the survey: inhabitants of the 3 territories, those living on reserves and other Aboriginal settlements, full-time members of the Canadian Forces, and individuals who were institutionalized. These excluded individuals represented approximately 3% of the target population in the 2012 cycle.
Data collection
The CCHS-MH was administered using computer-assisted personal interviewing. This method was chosen to allow for the customization of interviews based on each participant's characteristics and survey responses, as well as automatic correction for inconsistent or out-of-range responses. Interviews were conducted in person or by telephone, with the majority occurring in person. Proxy interviews were not used for this survey.
Data were collected from May to December 2002 for the 2002 cycle of the CCHS-MH. The total sample size was 36,984 with a response rate of 77%. For the 2012 cycle, data collection occurred between January and December 2012. The overall response rate for the survey was 68.9%, providing a total sample of 25,113 individuals. The present study examined adults aged 20 years or older, resulting in the exclusion of younger respondents.
Minimizing nonresponse
Before the interviewer made any contact with participants, each selected respondent was sent a letter and brochure that explained the survey's importance and the potential uses for the data. Additionally, when necessary, interviewers called and visited selected households on multiple occasions to encourage participation and maximize the response rate.
Weighting
In probability sampling, each participant in the sample represents multiple members of the population as well as himself or herself. A sampling weight was calculated for each respondent based on the number of individuals in the total population that were represented by that respondent. The inclusion of sampling weights in analyses is necessary for estimates to be representative of the entire population rather than the sample.
Study variables
This study examined insomnia symptoms in Canadian adults. Insomnia symptomatology was assessed using the question "How often do you have trouble going to sleep or staying asleep?" Responses were rated on a 5-point scale from 1 (none of the time) to 5 (all of the time). Participants who reported having trouble sleeping "most of the time" or "all of the time" were considered to have poor sleep. Age was divided into three groups: 20 to 39 years, 40 to 59 years, and 60 to 80 years and older. Sex was a binary variable with male and female as the 2 options. Demographic information, including marital status, education level, and province of residence, was also reported to characterize the sample.
Analyses
Frequencies were tabulated to characterize the sample based on demographic information, and χ 2 analyses were used to assess differ- To evaluate whether the change in odds of insomnia by year of analysis was differentially predicted by age, sex, and health groups, interaction terms were computed for year-by-age, year-by-sex, year-by-education, year-by-mental health, and year-by-physical health. All significant interactions were followed up by post hoc stratified analyses adjusted for all other covariates. In addition, a 3-way interaction was computed for year-by-age-by-sex, with post hoc stratified analyses.
Results
Demographic information
Characteristics of the sample are reported in Table 1 Prevalence of poor sleep Table 2 presents the results of the unadjusted and adjusted logistic regression analyses examining the relationship of year (2002 vs 2012) to change in insomnia symptoms. In the unadjusted analysis, the likelihood of insomnia increased by approximately 12% between 2002 and 2012. After adjusting for age, sex, and education, the likelihood of insomnia symptoms increased to approximately 16%. After further adjustment for mental and physical health, the likelihood of insomnia symptoms was attenuated to approximately 9%. All of these were statistically significant (all P b .001). In the stratified analyses, adjusted for all covariates, all interaction terms were also significant (P b .0005). Of note, the likelihood of insomnia symptoms was significantly greater in 2012 vs 2002 only among those ages [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] (approximately 16% increased likelihood of insomnia symptoms), among women (approximately 14% increased likelihood of insomnia symptoms), among those with at least a secondary education (approximately 13%, 22%, and 8% increased likelihood among those with secondary, some postsecondary, and postsecondary degree, respectively), among those in "very good" physical health (approximately 17% increased likelihood), and among those with either "good" or "fair/poor" mental health (approximately 9% and 23% increased likelihood, respectively). Those in other categories did not see a significant difference in prevalence of insomnia symptoms between 2002 and 2012. A year-by-age-by-sex 3-way interaction was statistically significant (P b .0005). Results of stratified analyses (both unadjusted and adjusted for mental and physical health) are presented in Table 3 . When all age groups were further stratified by sex, increased likelihood of insomnia symptoms in 2012 vs 2002 was seen among women aged 40-59 in both unadjusted and adjusted analyses (approximately 29% and 24% increased likelihood, respectively). Increased likelihood of insomnia symptoms in 2012 vs 2002 was also seen among women 60 or older, but only in the adjusted analysis (approximately 14% increased likelihood).
Discussion
This is the first study to investigate the prevalence of, and factors associated with, insomnia symptoms among Canadian adults between 2002 and 2012. The prevalence of insomnia symptoms experienced a modest increase of 1.5% across the 10-year span. The overall results of this study are consistent with population-based surveys that have been conducted elsewhere, including the United States, 1 Finland, 15 Norway, 13 and the United Kingdom, 14 which suggest that there has been a widespread increase in insomnia symptoms internationally. Interestingly, this increase in insomnia symptoms seems to have been primarily driven by women in the 40-to 59-year age range. Women 60+ also experienced an increase in insomnia symptoms, but only after adjusting for health status. Findings from the United States are consistent with the present study in that both females and individuals between the ages of 55 and 64 had the highest prevalence of insomnia symptoms. 1 Similarly, research in other countries has shown that females have higher levels of insomnia symptoms, although the effect of age has been less consistent. [13] [14] [15] This finding may be due in part to a reduction in the use of hormone replacement therapy to treat menopause-related symptoms. Menopause, in the absence of hormonal therapy, is associated with insomnia symptoms including increased sleep latency, difficulty staying asleep, and early morning awakenings, as well as decreased levels of restorative slow-wave sleep. 16, 17 Hormonal therapy has been shown to promote sleep among menopausal women, likely by reducing hot flashes and night sweats, 18 but it is also associated with an increased risk of breast and ovarian cancers. 19 The identification of this risk has resulted in an appreciable decline in the prescription of hormonal therapy in North America. 20 Perhaps, then, it is this decreased prevalence of hormonal therapy use among menopausal and postmenopausal women that partially accounts for the greater reported levels of poor sleep among women in the 40-to 59-year age range. Unfortunately, questions about hormonal therapy use were not asked consistently across provinces or time points in the CCHS-MH survey, so we were unable to investigate this potential effect. A further possible explanation for the increase in insomnia symptoms among middle-aged women is the greater level of psychosocial stress that is often experienced by this group. Women aged 40-59 commonly fall within the so-called "sandwich generation", a label that is given to those that provide care both for their own or others' children and for aging parents. 21 Membership in the sandwich generation is associated with diminished health-promoting behaviors, 21 greater occurrence of chronic disease including hypertension and depression. [21] [22] [23] The literature illustrates that sleep may be negatively impacted in this group both directly and indirectly given the known robust association between increased stress levels and insomnia symptoms.
24
There is also an increasing trend toward later motherhood. In North America as well as in many parts of Europe, the shift toward later first births began in the early 1970s 25 and has been reflected in an average age of first-time mothers in Canada of 28.5 years in 2011. 26 Additionally, over half of all Canadian births (52%) were to women aged 30 or older. 26 This trend has been accompanied by a similar delay in other markers of adulthood: both women and men now take longer to complete their education, to become established in the workforce, and to gain financial independence from their families, and both sexes are also postponing marriage. 26 This shift suggests that many of the stressors associated with establishing a financially stable household and raising young children have been delayed until closer to middle age, at which time women are already at a greater risk of sleep disturbance due to menopause and membership in the "sandwich generation".
To support women at this vulnerable age, it may be beneficial to explore nonhormonal treatment options for managing menopausal symptoms, such as gabanergics, 27 selective serotonin reuptake inhibitors, 28 or serotonin-norepinephrine reuptake inhibitors. 29 These medications improve sleep quality by reducing hot flashes and have fewer associated risks than hormonal therapies. 30 Equally important, it may be necessary to promote nonpharmacological methods to improve sleep quality among middle-aged women. Interventions such as cognitive-behavioral therapy for insomnia, 31 mindfulness-based stress reduction, 32 acupuncture, 33 and physical activity 34 may help reduce sleep problems caused by menopausal symptoms or stress. Employers may also see the benefits of improved sleep among their workforce if they advocate for work-life balance in this 24-hour society and culture of increased stress. Interestingly, insomnia symptoms increased among physically healthy participants. This was surprising because physical health problems are strongly associated with poor sleep 35 and may suggest that poor sleep is becoming more of a problem for otherwise healthy people. It is possible that many people see poor sleep as part of their lifestyle rather than a legitimate health concern. Chronic stress, long work hours, and circadian disrupting technology use are ubiquitous in modern society and could be contributing to and maintaining insomnia symptoms in healthy adults. 36, 37 Additionally, participants' health status was based on how they perceived their own health. It is possible that participants did not consider their sleep quality when assessing their health and therefore classified themselves as physically healthy despite having trouble sleeping. Another possible explanation is that with the increasing attention and recognition, individuals may be more aware of the importance of sleep and rate themselves as poor sleepers because they feel that their sleep is not as optimal as it could or should be. All of these hypotheses would require additional investigation before any firm explanations would be possible.
There was also an increase in insomnia symptoms in participants reporting good and fair/poor mental health compared to those with very good or excellent mental health. This is not surprising considering that sleep disturbances are symptoms of many psychological disorders, particularly mood and anxiety disorders; however, insomnia is now considered to be a distinct diagnostic entity even when it occurs simultaneously with a medical and/or psychiatric condition. 3 It is also the case that insomnia does not often remit with the treatment of the concurrent disorder, requires its own specific intervention, [38] [39] [40] and can increase the risk of developing a mood disorder. 41 The
American College of Physicians has released a practice guideline recommending cognitive-behavioral therapy as a first-line treatment for insomnia. 42 The increase observed in individuals reporting good and fair/poor mental health supports the need for increased access to evidence-based sleep interventions alongside more traditional mental health services. 43, 44 We found an increased prevalence of insomnia symptoms in individuals with higher levels of education compared to individuals without a secondary education. Educational attainment is intricately tied to socioeconomic status. Previous research has found a relationship between lower AND higher socioeconomic status, level of education, and insomnia symptoms, [45] [46] [47] [48] suggesting that there are factors that contribute to poor sleep at both ends of the socioeconomic status continuum. Clearly, this is a complex and multifactorial relationship complicated by interactions with other demographic and economic factors. This study had several limitations. First, participants were categorized as having insomnia symptoms based on a single question. The use of a single item precludes assessing for comorbid sleep disorders or medical conditions, such as obstructive sleep apnea or chronic pain, which may contribute to insomnia symptoms. It also prevents speculation about the clinical significance of the insomnia symptoms and the true prevalence of insomnia disorder. That said, it is not uncommon in population-based studies for insomnia to be assessed using a single question. 15 This limitation is further mitigated by the fact that the proportion of individuals reporting poor sleep in this study was similar to rates observed by Morin et al 2 in their survey of 2000 Canadians. Using the diagnostic criteria for insomnia, 13.4% of their sample had insomnia disorder and 16% exhibited symptoms of insomnia. 2 The similar prevalence rates reported here suggest that the question used was an efficient and reliable approximation of insomnia symptoms at a population level. Second, there was no time frame associated with the sleep question, which may have affected response accuracy because participants were not given a specific period to reflect upon when selecting their responses. This lack of a specified timeframe of reported insomnia symptoms prevents the determination of whether their trouble sleeping was due to transient/acute or chronic insomnia. A final limitation is the use of self-reported data; however, individuals' experience of poor sleep is highly subjective and not necessarily related to more objective sleep measures, making self-reports the most appropriate form of measurement. 49, 50 Our findings have demonstrated an increase in insomnia symptoms in Canadian adults between the years 2002 and 2012, particularly among women in the 40-to 59-year age range. Future research should investigate the potential roles of menopausal symptoms and treatment, later motherhood, and caregiving stress in exacerbating insomnia symptoms among middle-aged women. An improved understanding of the reasons for this phenomenon will allow for the development of targeted prevention and intervention initiatives to reduce the negative impact on physical and mental health, as well as the economic burden of insomnia on the Canadian population.
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